4D Molecular Therapeutics, Inc. - FDMT Qarzning balans qiymatiga nisbati

4DMT (FDMT) grafik logotipi

4D Molecular Therapeutics (FDMT) noyob vektor tizimi orqali innovatsion dori vositalarini ishlab chiqadi, bu esa kompaniyaga o'z terapiyalarining narxlari bo'yicha istisno darajadagi boshqaruv imkoniyatini beradi. Biznes barqaror tibbiy talabga tayangan bo'lsa-da, u komponentlarni yetkazib berish va intellektual mulk huquqlarini xorijda himoya qilish bilan bog'liq logistik qiyinchiliklarga duch kelmoqda. Joriy ko'rsatkich 0.09 darajasida turibdi. Ushbu kunlik narxlar grafigi faoliyatlar gumanitar maqom bilan himoyalangan AQSh yurisdiksiyasi doirasidagi operatsion barqarorlikni tasdiqlaydi.

FDMT (4D Molecular Therapeutics) Qarzning balans qiymatiga nisbati tarixi 04.07.2022dan 28.10.2026gacha

FDMT (4DMT): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi 4D Molecular Therapeutics|FDMT - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi 4D Molecular Corp|FDMT - Korxona qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga xususiy kapital 4D Molecular Therapeutics|FDMT - Kompaniyaning sof aktivlari|Balans qiymatiga nisbatan bozor qiymati 4dmoleculartherapeutics.com|FDMT - Kompaniyaning jami aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati 4D Molecular Therapeutics|FDMT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati 4D Molecular Therapeutics Inc|FDMT - Kompaniya qarzlari|Qarzning balans kapitallashuviga nisbati 4D Molecular Corp|FDMT - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz 4D Molecular Therapeutics
Kompaniyaning jamlanma tahliliyoti:4D Molecular Therapeutics FDMT
4dmoleculartherapeutics.com original mahsuloti

4D Molecular Therapeutics (FDMT) kompaniyasining sovuq zanjir logistikasining samarali rivojlanishi, balans kapitalizatsiyasiga nisbatan majburiyatlar koeffitsiyenti bilan birgalikda, gen terapiyasi kengayishining barqarorligini baholash imkonini beradi. Umumiy qarzdorlikni sof aktivlar qiymatiga bo'lish "qiymat tuzog'i" xavfini ochib beradi, bu esa fundamental past baholanganlikni kredit bosimidan ajratadi va ishlab chiqarishni kengaytirishda kapital likvidligini tushunish uchun juda muhimdir.

Raqobatchilar tahlili

Balans kapitallashuviga qarzlar TEM (Tempus AI Inc)|QGEN: Balans kapitallashuviga qarzlar|Ionis - Qarzning balans qiymatiga nisbati|RGEN (Repligen Corp) - Balans kapitallashuviga qarzlar|RNA (Avidity) - Qarzning balans qiymatiga nisbati|CRISPR - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati GeneDx Holdings Corp.|Qarzning balans kapitallashuviga nisbati ultragenyx.com (RARE)|Qarzning balans qiymatiga nisbati Beam Therapeutics (BEAM)|SRPT - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar Twist Bio TWST|10x - Qarzning balans kapitallashuviga nisbati|Intellia Therapeutics - Qarzning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar stoketherapeutics.com|BLFS: Balans qiymatiga qarzlar|Balans kapitallashuviga qarzlar Wave Life Sciences Ltd|Qarzning balans qiymatiga nisbati MAZE|Qarzning balans qiymatiga nisbati Sionna Corp|Balans kapitallashuviga qarzlar Prime Medicine, Inc. (PRME)|Qarzning balans kapitallashuviga nisbati TSHA (tayshagtx.com)|Qarzning balans kapitallashuviga nisbati QURE (uniQure)|Balans kapitallashuviga qarzlar MeiraGTx Holdings MGTX|RGNX - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati SLDB (Solid Corp)|OCGN (Ocugen, Inc.) - Qarzning sof aktivlarga nisbati|pacb.com - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati BNTC|DSGN (Design Therapeutics Inc) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitaliga nisbati RCKT|LXEO (lexeotx.com) - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati KRRO (Korro Bio)|editasmedicine.com (EDIT) - Balans kapitallashuviga qarzlar|SLN - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati PRQR (ProQR Therapeutics N.V.)|CDXS: Qarzning sof aktivlarga nisbati|Sangamo BioSciences (SGMO) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar Nautilus Biotechnology, Inc.|metagenomi.co - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati DTIL|GBIO - Balans kapitallashuviga qarzlar|Boundless Bio, Inc - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati Exicure Inc. XCUR|IMNN: Balans kapitallashuviga qarzlar|Phio Pharmaceuticals - Qarzning balans qiymatiga nisbati|MBIO: Qarzning balans kapitaliga nisbati|RNAZ - Balans kapitallashuviga qarzlar|BNGO (Bionano Genomics Inc.) - Sof aktivlarga qarzlar|Balans kapitallashuviga qarzlar Applied DNA Corp (APDN)|Qarzning balans qiymatiga nisbati bluebird bio, Inc. (BLUE)|Qarzning balans kapitallashuviga nisbati immunoprecise.com|Sof aktivlarga qarzlar OMGA (Omega Therapeutics, Inc.)|OMIC (Singular Genomics Systems, Inc.) - Balans kapitallashuviga qarzlar|Regulus Therapeutics Inc - Qarzlarning balans kapitallashuviga nisbati|SYRS (Syros Pharmaceuticals, Inc) - Balans kapitallashuviga qarzlar|Telesis Bio, Inc. (TBIO) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati traconpharma.com|Qarzning balans qiymatiga nisbati UBX